ORMP
Oramed Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.01
+1.62%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.05x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- -0.10x
Liquidity & coverage
- Current ratio
- 4.98x
- Quick ratio
- 4.98x
- Cash ratio
- 4.72x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $42.7M
Cash & dividend
- FCF / debt
- -7.33x
- Cash flow / debt
- -7.60x
- Dividend per share
- $0.25
- Dividend yield
- 5.0%
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026